Trials / Unknown
UnknownNCT04456075
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure. Predictors for early detection and risk stratification are urgently needed. Moreover, only scarce information is available for long-term follow-up and late complications associated with infection. We therefore aimed to find predictors for severe courses of the novel disease as well as to establish strategies for therapeutic monitoring and follow-up.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2020-07-02
- Last updated
- 2020-07-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04456075. Inclusion in this directory is not an endorsement.